RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

April 1, 2024

Conditions
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Interventions
OTHER

Evaluation of therapeutical approach after ASCT

Evaluation of therapeutical approach after ASCT

Trial Locations (15)

Unknown

RECRUITING

Hospital Nacional Posadas, El Palomar

RECRUITING

Hospital Italiano de La Plata, La Plata

RECRUITING

Hospital de Alta Complejidad El Cruce, San Juan Bautista

RECRUITING

Hospital San Martín, Paraná

RECRUITING

Instituto Privado de Hematologia y Hemoterapia, Paraná

RECRUITING

Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas

RECRUITING

IDHEA Clínica Hematológica, Rosario

RECRUITING

CEMIC, CABA

RECRUITING

FLEMING, CABA

RECRUITING

FUNDALEU, CABA

RECRUITING

Hospital Alemán, CABA

RECRUITING

Instituto de Trasplantes de Alta Complejidad, CABA

RECRUITING

Sanatorio Anchorena, CABA

RECRUITING

Clínica Universitaria Reina Fabiola, Córdoba

RECRUITING

Hospital Privado de Córdoba, Córdoba

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Grupo Argentino de Tratamiento de la Leucemia Aguda

OTHER